Summary:
Experts say it means there are "fewer obstacles for the immune system to neutralise the virus with antibodies". The world's biggest pharmaceutical company, Johnson & Johnson, told Sky News last month it was confident it had formulated a COVID-19 vaccine and wanted to make available on a not-for-profit basis in 2021. The firm hopes to begin human trials in September, which could mean mass production by early next year. The HIV comparison is significant, as the research was done using special equipment previously provided by a grant from the Bill and Melinda Gates Foundation through the Collaboration for AIDS Vaccine Discovery. Coronavirus: Vaccine hopes boosted as scientists find virus has 'low shielding'
Topics:
Mike Norman considers the following as important:
This could be interesting, too:
Experts say it means there are "fewer obstacles for the immune system to neutralise the virus with antibodies". The world's biggest pharmaceutical company, Johnson & Johnson, told Sky News last month it was confident it had formulated a COVID-19 vaccine and wanted to make available on a not-for-profit basis in 2021. The firm hopes to begin human trials in September, which could mean mass production by early next year. The HIV comparison is significant, as the research was done using special equipment previously provided by a grant from the Bill and Melinda Gates Foundation through the Collaboration for AIDS Vaccine Discovery. Coronavirus: Vaccine hopes boosted as scientists find virus has 'low shielding'
Topics:
Mike Norman considers the following as important:
This could be interesting, too:
Peter Radford writes Lost opportunities?
Joel Eissenberg writes Oh, Elon!
Angry Bear writes Role Of Medicaid Accountable Care Orgs In Maternal Health
NewDealdemocrat writes April consumer prices: still an interplay of gas and house prices, with a side helping of motor vehicle insurance
Experts say it means there are "fewer obstacles for the immune system to neutralise the virus with antibodies".
The world's biggest pharmaceutical company, Johnson & Johnson, told Sky News last month it was confident it had formulated a COVID-19 vaccine and wanted to make available on a not-for-profit basis in 2021.
The firm hopes to begin human trials in September, which could mean mass production by early next year.
The HIV comparison is significant, as the research was done using special equipment previously provided by a grant from the Bill and Melinda Gates Foundation through the Collaboration for AIDS Vaccine Discovery.